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Background: Diffusion-weighted magnetic resonance imaging (DW-MRI) is different from conventional diagnostic
methods and has the potential to delineate the microscopic anatomy of a target tissue or organ. The purpose of
our study was to evaluate the value of DW-MRI in the diagnosis of benign and malignant breast masses, which
would help the clinical surgeon to decide the scope and pattern of operation.
Methods: A total of 52 female patients with palpable solid breast masses received breast MRI scans using routine
sequences, dynamic contrast-enhanced imaging, and diffusion-weighted echo-planar imaging at b values of 400, 600,
and 800 s/mm2, respectively. Two regions of interest (ROIs) were plotted, with a smaller ROI for the highest signal and a
larger ROI for the overall lesion. Apparent diffusion coefficient (ADC) values were calculated at three different b values
for all detectable lesions and from two different ROIs. The sensitivity, specificity, positive predictive value, and positive
likelihood ratio of DW-MRI were determined for comparison with histological results.
Results: A total of 49 (49/52, 94.2%) lesions were detected using DW-MRI, including 20 benign lesions (two lesions
detected in the same patient) and 29 malignant lesions. Benign lesion had a higher mean ADC value than their
malignant counterparts, regardless of b value. According to the receiver operating characteristic (ROC) curve, the
smaller-range ROI was more effective in differentiation between benign and malignant lesions. The area under
the ROC curve was the largest at a b value of 800 s/mm2. With a threshold ADC value at 1.23 × 10−3 mm2/s, DW-MRI
achieved a sensitivity of 82.8%, specificity of 90.0%, positive predictive value of 92.3%, and positive likelihood ratio of 8.3
for differentiating benign and malignant lesions.
Conclusions: DW-MRI is an accurate diagnostic tool for differentiation between benign and malignant breast lesions,
with an optimal b value of 800 s/mm2. A smaller-range ROI focusing on the highest signal has a better differential
value.
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Breast cancer is a common malignancy and cause of cancer
death [1]. Despite improvements in the detection of breast
cancer with the widespread application of mammography
and ultrasonography, differentiation between benign and
malignant breast lesions remains a difficult diagnostic
problem [2]. Magnetic resonance imaging (MRI) is an
established supplementary technique to mammography
and ultrasonography for the evaluation of suspicious breast* Correspondence: jun_yangjy@163.com
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unless otherwise stated.lesions and primarily advantageous in its higher sensitivity
over both mammography and ultrasonography [3,4].
Diffusion-weighted MRI (DW-MRI) is an advanced
MRI technique, which emerged in the mid-1980s and al-
lows the mapping of in-vivo water diffusion processes in
a non-invasive manner; it can delineate the microscopic
anatomy of a target tissue or organ [5]. It has a higher
sensitivity and specificity in detecting suspicious breast
disease at a minimum size of 1 cm than regular MRI [5].
It can provide digital biomarker measurements of tissue
properties that are highly relevant to the assessment of
tumor progression or responses [6,7]. Diffusion-weightedis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 A representative case of benign breast lesion: sclerosing mastopathy (in a 53-year-old patient). (A) Axial diffusion-weighted MRI
map. The lesion shows as an oval mass with a circumscribed margin. (B) Axial apparent diffusion coefficient (ADC) imaging (b value is 800 s/mm2): The
ADC of the lesion is 1.96 × 10−3 mm2/s. (C) Micrograph with H & E stain (original magnification, 200×). The lobule of the mammary gland
displays adenomatoid hyperplasia and extensive fibrous stroma and demonstrates pseudoinvasion.
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ment at the diffusion scale and quantifies such diffusion ac-
cording to an index that reflects the apparent freedom of
diffusion, called the apparent diffusion coefficient (ADC). It
has been reported to produce higher detection rates than
conventional methods [6,8] and can be easily adopted as an
adjunct to standard clinical imaging protocols [9,10]. How-
ever, the reported sensitivity and specificity of DW-MRI
among previous reports is varied, possibly owing to the
variability of MRI equipment and scanning parameters,
such as definition of the b value (the strength of the mag-
netic diffusion gradient) and region of interest (ROI) [5,11].
The primary objective of this study was to evaluate the
role of DW-MRI in the diagnosis of benign and malignant
breast masses. Moreover, we also attempted to optimize
the b value, to improve the differential capability of DW-
MRI between benign and malignant breast masses.
Methods
Patients
This study included 52 women (age range: 20 to 86 years)
who underwent breast DW-MRI between March 2008
and March 2010 at Tong Ren Hospital Affiliated to
Shanghai Jiao Tong University school of medicine
(Shanghai, PR China) because of clinical abnormality or
suspicious findings on breast ultrasonography. The
sources of specimens for histological examination were
surgical excision (48 cases) and core needle biopsy (4
cases). A total of 31 cases were detected in the left
breast, and 21 were detected in the right breast. AllFigure 2 A case of malignant breast lesion: invasive lobular carcinom
b value of 800 s/mm2, showing scattered foci with high signal intensity. (B) A
benign lesion, owing to the ADC cut-off value of 1.23 × 10−3 mm2/s. (C) Micro
space that small cancer cells form is extensive.patients had DW-MRI prior to the biopsy or surgical
procedure. Patients under neoadjuvant chemotherapy,
with history of breast biopsy within 1 month, without a
detectable lesion on MRI corresponding to a clinically or
mammographically defined lesion, and without histo-
pathologic confirmation of the lesion were excluded
from the study. This retrospective study was approved
by the institutional review board and ethics committee
of Tong Ren Hospital Affiliated to Shanghai Jiao Tong
University, Shanghai, China. Written informed consent
was obtained from all patients before MRI.
MRI image acquisition
MRI was performed using a 1.5 T MR system (Sigma
Excite II; GE Medical System, Milwaukee, WI, USA) and
a dedicated phased-array bilateral breast coil, with the
patient lying prone and the breast in a holder to reduce
motion [12]. Prior to diffusion weighting, fast recovery
fast spin echo was performed in the axial plane, three-
dimensional fast spoiled gradient recalled acquisition in
the steady state (3DFSPGR) with Spec IR for fat satur-
ation in the sagittal plane was performed before and
after administration of gadopentetate dimeglumine
(0.2 mmol/kg). Subtraction images were produced with
3DFSPGR for identification of enhancement. Two-
dimensional fast spoiled gradient recalled acquisition
in the steady state in the axial plane was performed
after enhancement. Imaging parameters were as fol-
lows: T1 sagittal plane, repetition time (TR)/echo time
(TE) = 480/10.4 ms, number of excitations (NEX) = 2,a (in a 71-year-old patient). (A) Axial diffusion-weighted MRI map with
DC map. The absolute ADC is 1.61 × 10−3 mm2/s, which is consistent with
graph with H & E stain (original magnification, 400×). The extracellular


















Fibroadenoma 10 10 0.6 to 4.8









26 26 1.0 to 3.6
Invasive lobular
carcinoma
3 3 1.2 to 3.5
Total 52 49
MRI, magnetic resonance imaging.
Table 3 Effect of b value on ADC value difference
between large- and small-scale regions of interest for










400 0.07 0.15 0.03 to 0.12 0.001
600 0.07 0.13 0.03 to 0.11 0.001
800 0.05 0.12 0.01 to 0.08 0.008
ADC, apparent diffusion coefficient; MRI, magnetic resonance imaging.
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220 mm; T2 sagittal plane, TR/TE = 3,500/85 ms,
NEX = 3, slice thickness = 5 mm, and FOV = 220 mm;
axial plane, TR/TE = 4,000/85 ms, NEX = 3, slice thick-
ness = 4 mm, FOV = 160 mm. One pre-contrast and
six continuous dynamic contrast-enhanced spoiled gradi-
ent echo (SPGR) three-dimensional acquisitions were per-
formed using a rapid bolus injection of 0.2 mmol/kg
gadolinium-chelated diethylenetriaminepentaacetic acid
(Magnevist, Schering, Berlin, Germany), at a TR/TE of
6.6/2.2 ms, flip angle of 15°, and 3-mm slice thickness for
the sagittal plane. Diffusion-weighted axial images with
single-shot echo-planar imaging (TR/TE = 9,355 ms/
78.5 ms, matrix = 128 × 128, NEX = 4, FOV = 280 mm,Table 2 ADC values of MRI-detectable benign/malignant

















400 Benign 1.85 0.19 0.44 0.80 to 2.62 <0.001
Malignant 1.36 0.07 0.27 1.01 to 1.97
600 Benign 1.79 0.28 0.53 0.65 to 2.90 <0.001
Malignant 1.21 0.05 0.23 0.78 to1.79
800 Benign 1.66 021 0.46 0.64 to 2.47 <0.001
Malignant 1.11 0.04 0.19 0.78 to 1.69
ADC, apparent diffusion coefficient; MRI, magnetic resonance imaging.slice thickness = 5 mm, and slice gap = 0 mm) were cap-
tured at b values of 400, 600 and 800 s/mm2, respectively.
Double axial post-contrast SPGR T1-weighted imaging
was performed to complete the MRI scan.
Image analysis
Evaluation of images was performed in consensus by
two MRI-accredited radiologists with more than
5 years’ experience each. They were assigned to iden-
tify and locate the breast disease shown on DW-MRI
images by referring to the dynamic-enhanced imaging
(Figure 1A, Figure 2A). The DW-MRI quality was
assessed with respect to fat suppression, blurring and
other artifacts, and signal intensity [13,14]. Each pa-
tient had three ADC maps created at b values of 400,
600 and 800 s/mm2, respectively. Each ADC was
mapped in a colour or gray-scale format (Figure 1B,
Figure 2B). To resolve disagreement between observers,
a third radiologist (with 5 years of experience in breast
imaging and 20 years of experience in MRI) assessed all
involved items. Regions of interest were drawn in the
breast parenchyma in the center of the contralateral
breast, avoiding contamination by fatty tissue. The
ROIs were then copied and pasted onto the corre-
sponding ADC map for quantitative analysis. For each
ROI, we extracted the mean ADC and the ROI area [6].
The ADC values were automatically calculated using
the Functool 2 software of the GE ADW 4.1 worksta-
tion by placing two separate ROIs on the target lesions
and according to the equation:
ADC ¼ 1n Si=S0ð Þ= bi−b0ð Þ;
where S0 is the first acquired image at b = 0 s/mm
2, Si are
the corresponding images at b = 400, 600, and 800 s/mm2,
b0 is the b value, and bi is the diffusion gradient value.
The measuring area was kept constant among images
with three b values. Use of a higher b value reduced the
contribution of perfusion effects in ADC measurements,
according to the equation. Small differences between
ADC values were observed at lower b values, with larger
differences at higher b values. The lower ADC in malig-
nancies was primarily attributed to a higher cell density,
Figure 3 Comparison of receiver operating characteristic (ROC) curves for three b values. (A) Smaller-range region of interest for different
b values. (B) Larger range of region interest for different b values.
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there was an increased fraction of signal coming from
intracellular water. The regions selected as clearly identi-
fiable had high signal intensity on diffusion-weighted
MRI, yet we avoided regions of high signal intensity on
T2-weighted images, to exclude the T2 shine-through ef-
fect. A smaller-scale ROI was plotted on the highest-
signal area of the lesion at a minimum size of 26 mm2,
while a larger-scale ROI was also plotted, to outline the
full-scale disease. An oversized ROI (too large to outline
at full-scale) was divided into multiple smaller-scale
ROIs to produce the mean ADC. Diagnostic sensitivity,
specificity, positive predictive value, and positive likeli-
hood ratio of DW-MRI were produced for comparison
with histological results (Figure 1C, Figure 2C).Statistical analysis
The SPSS software package version 16.0 (SPSS Inc.,
Chicago, IL, USA) was used for statistical analysis.
Continuous data were expressed as mean ± standard
deviation and compared using the independent sample
Mann-Whitney U test or the paired Student-t test,
and nonparametric data were analyzed using the
related-samples Friedman test. The cut-off values dif-
ferentiating benign and malignant breast diseases were
defined using receiver operating characteristic (ROC)
curves. A two-tailed P < 0.05 was considered statisti-
cally significant.Table 4 Differentiation capability of ADC value for MRI-detec
b value
(s/mm2)
Mean ADC of benign
disease (×10−3 mm2/s)
Mean ADC of malignant
disease (×10−3 mm2/s)
Sensitivit
400 1.85 ± 0.86 1.36 ± 0.53 82.8%
600 1.79 ± 1.03 1.21 ± 0.45 86.2%
800 1.66 ± 0.90 1.11 ± 0.37 82.8%
ADC, apparent diffusion coefficient; MRI, magnetic resonance imaging.Results
Detectability on DW-MRI
All 52 patients enrolled in this study successfully under-
went DW-MRI for their suspicious breast findings and
had a histopathologic reference standard test for their
index lesion. Four of 52 lesions were not detected on
DW-MRI (detectability rate: 49/52, 94.2%), and all of the
four lesions were confirmed to be diffuse cystic masto-
pathy. There were 29 malignant lesions in 29 patients,
including 26 invasive ductal carcinomas in 26 patients
and 3 invasive lobular carcinomas in 3 patients. There
were 20 benign lesions in 23 patients, including one
fibrocystic changes in one patient, four instances of
plasma cell mastitis in three patients (two lesions were
detected in one of the three patient), one intraductal
papilloma in one patient, ten fibroadenoma in ten pa-
tients, two instances of mastopathy in six patients, one
sclerosing mastopathy in one patient, and one abscess in
one patient (Table 1). There was no significant difference
in the detection rate of DW-MRI among the three
b values (P > 0.05).
Imaging quality and signal analysis
Diffusion-weighted MRI exhibited a superior readability
with a good fat suppression and signal intensity in all pa-
tients, except for one patient with some margin artifacts.
Benign lesions showed a similar or slightly lower signal
intensity than parenchyma in ADC maps, while the great
majority of malignant lesions showed a significantlytable benign and malignant breast diseases (n = 49)
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non-mass-like enhancement on dynamic-enhanced im-
aging, the b value of 800 s/mm2 could significantly im-
prove the imaging of 11 lesions. It also exhibited a
significantly higher signal contrast between the lesions
and the parenchyma than b values of 400 and 600
s/mm2. No significant differences were observed in
mass-like enhancement among the three b values.Analysis of ADCs
The mean ADC for malignant masses was lower than
the mean ADC for benign lesions among three b values
(all P < 0.05; Table 2). The effect of the ROI scale on
ADC is shown in Table 3. The smaller- and larger-scale
ROIs exhibited statistically significant differences in
ADC. The ROC analysis showed that the smaller-scale
ROI was more effective in differentiating between benign
and malignant diseases (Figure 3). For b values of 400,
600 and 800 s/mm2, the ROC area under the curve was
0.847, 0.861, and 0.875, respectively. The area was lar-
gest when the b value was 800 s/mm2 (95% confidence
interval 0.746 to 1.004), indicating that a b value of
800 s/mm2 may be optimal for differentiation between
malignant and benign breast lesions.Sensitivity, specificity, positive predictive value, and
positive likelihood ratio
With a predefined ADC cut-off value at 1.23 × 10−3 mm2/s,
DW-MRI gave a sensitivity of 82.8%, specificity of 90.0%,
positive predictive value of 92.3%, and positive likelihood
ratio of 8.28, in differentiation between benign and malig-
nant diseases (Table 4). Three invasive ductal carcinoma
cases and two invasive lobular carcinoma cases among 29
malignant cases were misdiagnosed as benign; 1 adenosis
case and one abscess case out of 23 benign cases were mis-
takenly diagnosed as malignant.Table 5 ADC threshold and sensitivity/specificity of breast DW
Reference ADC threshold (×10−3 mm2/s)
Lalitha et al [23] 1.3 to 1.5/0.85 to 1.1(for benign/maligna
Zhang et al. [12] 1.24/1.2 (b = 500/1,000 s/mm2)
Luo et al. [24] 1.22
Reiko et al. [16] 1.6
Marini et al. [25] 1.1
Guo et al. [26] 1.3
Woodhams et al. [27] 1.6
Ruboseva et al. [19] 1.13
Hatakenaka et al. [28] 1.48
Pereira et al. [4] 1.21
Our study 1.23
ADC, apparent diffusion coefficient; DW-MRI, diffusion-weighted magnetic resonancDiscussion
This study assessed the role of DW-MRI in the diagnosis
of benign and malignant breast masses, with the goals of
providing guidance for clinical diagnosis. The results re-
vealed that DW-MRI had an overall detection rate of
94.2% for benign and malignant breast diseases, relatively
higher than that (86.2%) reported by Park et al. [15].
Moreover, the performance of DW-MRI was affected by b
value, ADC threshold, and ROI scale.
Visualization of DW-MRI depends on water molecule
diffusion, which will be influenced by histological struc-
ture; in other words, the signal intensity will imply the
histological structure. Diffusion is quantified by measuring
what is known as the ADC value in square millimeters per
second, which defines the average area covered by a
molecule per unit time. The ADC value can be calcu-
lated by assessing the signal attenuation that occurs
at diffusion-weighted imaging performed at different
b values [16]. Many factors can influence ADCs, in-
cluding imaging parameters and pathophysiologic
features of the lesions [16]. The motion of water mole-
cules is subject to more restriction in tissues with a
high cellular density or enriched with lipophilic barrier
membranes. Malignant tumors usually have a high cel-
lular density, contractible extracellular space, and great
absorption of biomass molecules, and consequently re-
strict water molecule diffusion.
Diffusion-weighted MRI has been accepted as a
powerful adjuvant to conventional MRI for reducing
false positivity in breast cancer screening. Prior investi-
gators (Table 5) have evaluated the role of MRI in breast
masses performed with 1.5 T systems and reported that
ADCs have the potential to help differentiate benign
from malignant lesions. Our results showed that DW-
MRI had an overall detection rate of 94.2% for benign
and malignant breast diseases, relatively higher than pre-
viously reported [15]. It also demonstrated that the-MRI
Sensitivity (%) Specificity (%)
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b values of 400, 600 and 800 s/mm2; however, a b value
of 800 s/mm2 produced a higher-contrast resolution be-
tween the non-mass-like enhancement tissue and the
normal parenchyma than did b values of 400 and 600 s/
mm2. Moreover, consistent with several previous studies
[4,17,18], the current study revealed that the ADC value
of malignant lesions was significantly lower than that of
benign lesions. The ADC exhibited a gradual increase
from the innermost layer to the outermost layer at the
tumor margin. In addition, accurate positioning of the
ROI is essential for an accurate measure of ADC [19].
Our results showed that the encompassed smaller-scale
ROI had a constantly smaller ADC and a better differen-
tial capability than the larger-scale counterpart. These
were consistent with previous studies [14–16,20–22].
Therefore, the smaller-scale ROI in DW-MRI was recom-
mended for differentiating benign and malignant breast
diseases.
There were some limitations to this retrospective
study. Firstly, although the total number of lesions eval-
uated was relatively large, there were a relatively small
number of benign diseases for each type. Secondly, with
the described technique, these processes could poten-
tially be automated for evaluation of the entire breast ra-
ther than a focal lesion; however, ADC determination
and ROI selection were conducted by a single blinded
reader. Finally, since all of the MRI examinations were
performed using a single MRI platform, the results
might be specific to certain pulse sequences. Despite
these limitations, DW-MRI of the breast provides add-
itional information for characterizing focal breast lesions
in a fast and easy way. In this series, we obtained sensitiv-
ity and specificity as high as 82.8% and 90.0%, respectively.
Nevertheless, further studies with larger populations are
needed to confirm the value of DW-MRI in the evaluation
of breast lesions.
Conclusions
In summary, the study revealed that DW-MRI had a good
performance in differentiating both benign and malignant
diseases at breast. With a b value of 800 s/mm2, an ADC
threshold at 1.23 × 10−3 mm2/s and an encompassed
smaller-scale ROI, breast DW-MRI exhibited a moderately
high sensitivity and specificity in differentiation between
benign and malignant lesions. Larger-scale randomized
controlled studies are required to validate the superiority
of DW-MRI.
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